First Manhattan’s Orthofix Medical OFIX Stock Holding History

First Manhattan’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-300	Closed	-$4.36K	–	1101
2024 Q1	$4.36K	Buy	+300	New	+$4.15K	﹤0.01%	1209

Other funds holding OFIX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan's OFIX Position: Q2 2024 in Review

First Manhattan sold out of Orthofix Medical (OFIX) in Q2 2024, closing a stake of 300 shares — an estimated $4.36K sold.

First Manhattan first reported a position in OFIX in Q1 2024 and held it in 1 quarter. The position peaked at $4.36K in Q1 2024. 130 funds tracked by Wall St. Rank hold OFIX as of Q2 2024.

First Manhattan reported no remaining Orthofix Medical position as of Q2 2024 after selling out during the quarter.
First Manhattan sold 300 Orthofix Medical shares in Q2 2024, an estimated $4.36K.
First Manhattan first reported a position in Orthofix Medical in Q1 2024 and held it in 1 quarter.
First Manhattan's Orthofix Medical position peaked at $4.36K in Q1 2024.
130 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2024.

Based on First Manhattan's 13F filing for Q2 2024, filed 14 Aug 2024.